Showing results 18 to 37 of 40
< previous
next >
Issue Date | Title | Author(s) |
2017-03-21 | Genetic correlation between amyotrophic lateral sclerosis and schizophrenia | McLaughlin, RL; Schijven, D; Van Rheenen, W; Van Eijk, KR; O'Brien, M; Kahn, RS; Ophoff, RA; Goris, A; Bradley, DG; Al-Chalabi, A; Van Den Berg, LH; Luykx, JJ; Hardiman, O; Veldink, JH; Shatunov, A; Dekker, AM; Diekstra, FP; Pulit, SL; Van Der Spek, RAA; Van Doormaal, PTC; Sproviero, W; Jones, AR; Nicholson, GA; Rowe, DB; Pamphlett, R; Kiernan, MC; Bauer, D; Kahlke, T; Williams, K; Eftimov, F; Fogh, I; Ticozzi, N; Lin, K; Millecamps, S; Salachas, F; Meininger, V; Carvalho, MD; Pinto, S; Mora, JS; Rojas-Garcyá, R; Polak, M; Chandran, S; Colville, S; Swingler, R; Morrison, KE; Shaw, PJ; Hardy, J; Orrell, RW; Pittman, A; Sidle, K; Fratta, P; Malaspina, A; Petri, S; Abdulla, S; Drepper, C; Sendtner, M; Meyer, T; Wiedau-Pazos, M; Lomen-Hoerth, C; Deerlin, VMV; Trojanowski, JQ; Elman, L; McCluskey, L; Basak, N; Meitinger, T; Lichtner, P; Blagojevic-Radivojkov, M; Andres, CR; Maurel, C; Bensimon, G; Landwehrmeyer, B; Brice, A; Payan, CAM; Saker-Delye, S; Durr, A; Wood, N; Tittmann, L; Lieb, W; Franke, A; Rietschel, M; Cichon, S; Nothen, MM; Amouyel, P; Tzourio, C; Dartigues, JF; Uitterlinden, AG; Rivadeneira, F; Estrada, K; Hofman, A; Curtis, C; Derkooi, AJV; De Visser, M; Weber, M; Shaw, CE; Smith, BN; Pansarasa, O; Cereda, C; Bo, RD; Comi, GP; D'Alfonso, S |
2006-02 | Handwashing practice and policy variability when caring for central venous catheters in paediatric intensive care. | Morritt, ML; Harrod, ME; Crisp, J; Senner, A; Galway, R; Petty, S; Maurice, L; Harvey, A; Hardy, J; Donnellan, R |
2019-09-01 | Harms From Haloperidol for Symptom Management in Palliative Care—a Post Hoc Pooled Analysis of Three Randomized Controlled Studies and Two Consecutive Cohort Studies | Matsuoka, H; Agar, M; Vandersman, Z; Good, P; Fazekas, B; Brown, L; Hardy, J; Weil, J; Currow, DC |
2018-03 | Impact of Opioid Therapy on Sleep and Respiratory Patterns in Adults With Advanced Cancer Receiving Palliative Care. | Good, P; Pinkerton, R; Bowler, S; Craig, J; Hardy, J |
2016-03 | Interventional options for the management of refractory cancer pain--what is the evidence? | Vayne-Bossert, P; Afsharimani, B; Good, P; Gray, P; Hardy, J |
2019-03-04 | Managing diabetes at the end of life–a retrospective chart audit of two health providers in Queensland, Australia | Alqabandi, N; Haywood, A; Kindl, K; Khan, S; Good, P; Hardy, J |
2023-06 | Medicinal cannabis in palliative medicine: lessons learnt from randomised controlled trials. | Gurgenci, T; Hardy, J; Olson, R; Huggett, G; Foster, K; Good, P |
2019-12-06 | Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: A double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD) | Good, P; Haywood, A; Gogna, G; Martin, J; Yates, P; Greer, R; Hardy, J |
2020-07-06 | Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). | Hardy, J; Haywood, A; Gogna, G; Martin, J; Yates, P; Greer, R; Good, P |
2010-02-01 | Patient care guidelines: A telephone survey of intensive care practices in New South Wales | Knowles, S; Rolls, K; Elliott, D; Hardy, J; Middleton, S |
2023-03-01 | Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD). | Hardy, J; Greer, R; Huggett, G; Kearney, A; Gurgenci, T; Good, P |
2013-11-01 | Placebo and nocebo effects in randomized controlled trials: The implications for research and practice | Sanderson, C; Hardy, J; Spruyt, O; Currow, DC |
2021-03 | Practice review: Evidence-based quality use of corticosteroids in the palliative care of patients with advanced cancer. | Hardy, J; Haywood, A; Rickett, K; Sallnow, L; Good, P |
2014-04-15 | Preliminary development and validation of a new endof-life patient-reported outcome measure assessing the ability of patients to finalise their affairs at the end of life | McCaffrey, N; Skuza, P; Breaden, K; Eckermann, S; Hardy, J; Oaten, S; Briffa, M; Currow, D |
2016 | Quantitative determination of the enantiomers of methadone in human plasma and saliva by chiral column chromatography coupled with mass spectrometric detection. | George, R; Lobb, M; Haywood, A; Khan, S; Hardy, J; Good, P; Hennig, S; Norris, R |
2018-05-02 | A randomized open-label study of guideline-driven antiemetic therapy versus single agent antiemetic therapy in patients with advanced cancer and nausea not related to anticancer treatment | Hardy, J; Skerman, H; Glare, P; Philip, J; Hudson, P; Mitchell, G; Martin, P; Spruyt, O; Currow, D; Yates, P |
2012-10-10 | Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain | Hardy, J; Quinn, S; Fazekas, B; Plummer, J; Eckermann, S; Agar, M; Spruyt, O; Rowett, D; Currow, DC |
2022-06-14 | Research agenda for medical cannabis in palliative care. | Gurgenci, T; Hardy, J; Good, P |
2012-09-01 | Sector-wide approach to phase III studies | Hardy, J; Currow, DC |
2016-09-01 | Single-patient multiple crossover studies to determine the effectiveness of paracetamol in relieving pain suffered by patients with advanced cancer taking regular opioids: A pilot study | Nikles, J; Mitchell, GK; Hardy, J; Senior, H; Carmont, SA; Schluter, PJ; Vora, R; Currow, D; Yelland, M |